Citation: | SUN Mingli, LIU Chen, WEI Yali, GAO Qian, LIU Qianying, WANG Xinghe. Bioequivalence of metformin hydrochloride sustained-release tablets under fed condition in healthy subjects[J]. Journal of China Pharmaceutical University, 2023, 54(1): 89-94. DOI: 10.11665/j.issn.1000-5048.20220922001 |
[1] |
.[
|
[2] |
Chinese Elderly Type 2 Diabetes Prevention and Treatment of Clinical Guidelines Writing Group,Geriatric Endocrinology and Metabolism Branch of Chinese Geriatric Society,Geriatric Endocrinology and Metabolism Branch of Chinese Geriatric Health Care Society,et al. Clinical guidelines for prevention and treatment of type 2 diabetes mellitus in the elderly in China (2022 edition)[J]. Chin J Intern Med(中华内科杂志),2022,61(1):12-50.
|
[3] |
Chinese Diabetes Society. Guideline for the prevention and treatment of type 2 diabetes mellitus in China (2020 edition)[J]. Chin J Diabetes (中华糖尿病杂志),2021,13(4):315-409.
|
[4] |
American Diabetes Association Professional Practice Committee. 2. classification and diagnosis of diabetes:standards of medical care in diabetes-2022[J]. Diabetes Care,2022,45(
|
[5] |
Wang LM,Peng W,Zhao ZP,et al. Prevalence and treatment of diabetes in China,2013-2018[J]. JAMA,2021,326(24):2498-2506.
|
[6] |
Jiang AF,Ma LP,Wang YX,et al. Efficacy and safety of metformin hydrochloride sustained release tablets and common metformin hydrochloride tablets in treatment of type 2 diabetes mellitus[J]. China Med(中国医药),2018,13(1):66-69.
|
[7] |
National Medical Products Administration (NMPA). Opinions of the general office of the state council on the consistency evaluation of the quality and efficacy of generic drugs(国务院办公厅关于开展仿制药质量和疗效一致性评价的意见)[EB/OL]. (
|
[8] |
Sun ML,Qi L,Luo XD,et al. Pharmacokinetic bioequivalence and safety assessment of two metformin hydrochloride tablet formulations using a phase I,randomized,open,two-period,two cross-over,single-dose,fed study in healthy Chinese adult subjects[J]. Int J Clin Pharmacol Ther,2021,59(9):630-638.
|
[9] |
Sun ML,Liu HJ,Luo XD,et al. Bioequivalence and safety assessment of two formulations of metformin hydrochloride sustained-release tablets (Yuantang? SR and Glucophage? XR) under fed conditions in healthy Chinese adult subjects:an open-label,two-way crossover,sequence randomized phase I clinical trial[J]. Drugs R D,2022,22(1):51-60.
|
[10] |
Sun ML,Qi L,Luo XD,et al. Bioequivalence of metformin hydrochloride tablets under fasting and single-dose conditions in adult healthy volunteers[J]. Chin J Clin Pharmacol(中国临床药理学杂志),2021,37(11):1307-1310.
|
[11] |
Sun ML,Qi L,Luo XD,et al. Bioequivalence and safety of metformin hydrochloride sustainedrelease tablets with single-dose oral administration under fasting conditions in Chinese healthy volunteers[J]. Chin J Pharmacol Toxicol(中国药理学与毒理学杂志),2021,35(11):830-836.
|
[12] |
Zhou ZY,Wang CX,Li M,et al. In vitro dissolution and in vivo bioequivalence evaluation of two metformin extended-release tablets[J]. Clin Pharmacol Drug Dev,2021,10(4):414-419.
|
[13] |
Sun ML,Liu C,Bai HH,et al. Bioequivalence and safety evaluation of two preparations of metformin hydrochloride sustained-release tablets (Boke? and Glucophage?-XR) in healthy Chinese volunteers:a randomized phase I clinical trial[J]. Ann Med,2022,54(1):2617-2626.
|
[14] |
Sun ML,Wang J,Song XX,et al. The safety of immediate release and sustained release formulations of metformin hydrochloride in Chinese healthy subjects[J]. Chin J New Drugs(中国新药杂志),2020,29(4):399-407.
|